← Back to Clinical Trials
Recruiting NCT06074796

The Determinants of Fertility Preservation in TRANSgender Patients.

Trial Parameters

Condition Fertility Preservation
Sponsor Central Hospital, Nancy, France
Study Type OBSERVATIONAL
Phase N/A
Enrollment 230
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2023-09-25
Completion 2024-03
Interventions
No intervention.

Brief Summary

The study is monocentric, retrospective, non-interventional and does not involve human subjects. The main objective is to compare the profiles of transgender patients who undergo fertility preservation with those who do not. The secondary objectives are to define the rate of recourse to fertility preservation, determine the proportion of patients wishing to become parents. Statistical analysis will be carried out with a view to highlighting significant determinants in transgender patients by comparing those who undergo fertility preservation with those who do not. The data will have been collected during routine consultations as part of the transition process for transgender patients. This is taking place in the reproductive medicine department of the regional university hospital centre in Nancy.

Eligibility Criteria

Inclusion Criteria: * Transgender patients who consulted the Assisted Reproductive Technology centre of the Nancy Regional University Hospital, between 1st January 2020 and 30th June 2023. The consultations occurred for the start of transition care, for follow-up or for a parenting project for transgender patients. Exclusion Criteria: * minors * patients under guardianship or under tutelage

Related Trials